Try our Advanced Search for more refined results

Gilead Stalled On HIV Prevention Approval For Truvada

By Amanda Bransford (June 8, 2012, 5:13 PM EDT) -- The U.S. Food and Drug Administration has delayed by three months a decision on whether Gilead Sciences Inc. can expand the indications for its HIV drug Truvada to include prevention of the virus in uninfected people, Gilead said Friday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!